Medico Remedies Limited (MEDICO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medico Remedies Limited (MEDICO) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs6.43 Million ≈ $69.54K USD) by net assets (Rs668.58 Million ≈ $7.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Medico Remedies Limited (MEDICO) total market value for the company's overall valuation and market capitalisation.
Medico Remedies Limited - Cash Flow Conversion Efficiency Trend (2013–2026)
This chart illustrates how Medico Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medico Remedies Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medico Remedies Limited ranked by their cash flow conversion efficiency. Explore Medico Remedies Limited earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aarey Drugs & Pharmaceuticals Limited
NSE:AAREYDRUGS
|
0.006x |
|
Maquia Capital Acquisition Corp
NASDAQ:MAQC
|
0.008x |
|
Century Lithium Corp.
V:LCE
|
-0.005x |
|
NPD Co. Ltd
KQ:198080
|
0.037x |
|
ORTOMA AB B
F:82Y
|
-0.120x |
|
Jeil Steel Mfg Co. Ltd
KQ:023440
|
-0.047x |
|
Dusk Group Ltd
AU:DSK
|
-0.078x |
|
TDb Split Corp
TO:XTD
|
-0.045x |
Annual Cash Flow Conversion Efficiency for Medico Remedies Limited (2013–2026)
The table below shows the annual cash flow conversion efficiency of Medico Remedies Limited from 2013 to 2026. View MEDICO live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs754.74 Million ≈ $8.16 Million |
Rs10.06 Million ≈ $108.82K |
0.013x | -82.98% |
| 2025-03-31 | Rs624.69 Million ≈ $6.76 Million |
Rs48.92 Million ≈ $529.06K |
0.078x | +68.23% |
| 2024-03-31 | Rs523.71 Million ≈ $5.66 Million |
Rs24.38 Million ≈ $263.65K |
0.047x | -75.01% |
| 2023-03-31 | Rs438.43 Million ≈ $4.74 Million |
Rs81.67 Million ≈ $883.25K |
0.186x | +18.60% |
| 2022-03-31 | Rs373.20 Million ≈ $4.04 Million |
Rs58.62 Million ≈ $633.95K |
0.157x | +145.08% |
| 2021-03-31 | Rs324.58 Million ≈ $3.51 Million |
Rs-113.10 Million ≈ $-1.22 Million |
-0.348x | -1175.78% |
| 2020-03-31 | Rs298.66 Million ≈ $3.23 Million |
Rs9.67 Million ≈ $104.62K |
0.032x | -81.43% |
| 2019-03-31 | Rs282.36 Million ≈ $3.05 Million |
Rs49.24 Million ≈ $532.54K |
0.174x | -8.75% |
| 2018-03-31 | Rs266.66 Million ≈ $2.88 Million |
Rs50.97 Million ≈ $551.17K |
0.191x | +202.51% |
| 2017-03-31 | Rs163.72 Million ≈ $1.77 Million |
Rs-30.52 Million ≈ $-330.12K |
-0.186x | +26.28% |
| 2016-03-31 | Rs147.44 Million ≈ $1.59 Million |
Rs-37.29 Million ≈ $-403.27K |
-0.253x | -980.71% |
| 2015-03-31 | Rs136.14 Million ≈ $1.47 Million |
Rs-3.19 Million ≈ $-34.46K |
-0.023x | -107.36% |
| 2014-03-31 | Rs85.72 Million ≈ $927.00K |
Rs27.27 Million ≈ $294.96K |
0.318x | -21.78% |
| 2013-03-31 | Rs50.55 Million ≈ $546.71K |
Rs20.57 Million ≈ $222.40K |
0.407x | -- |
About Medico Remedies Limited
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more